| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 726346 | 07386008IP2 | TOVIAZ 8 MG COMPRIMIDOS DE LIBERACION PROLONGADA | TOVIAZ 8 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 28 comprimidos | 8 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07386008IP2/07386008IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07386008IP2/07386008IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | MELYFARMA S.L. | 2019-07-10 | 1 | 1 | 1 | 2019-07-11 | 2019-07-10 | 1 | 2019-09-12 | View Edit Delete | ||||||||||||
| 658953 | 07387014 | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 0,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387014/07387014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387014/07387014_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658954 | 07387017 | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA 30 cápsulas | 1 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387017/07387017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387017/07387017_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658956 | 07387019 | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 60 cápsulas | 1 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387019/07387019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387019/07387019_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 662915 | 07387021 | ADVAGRAF 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387021/07387021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387021/07387021_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658957 | 07387024 | ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387024/07387024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387024/07387024_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 659170 | 07389001 | ORENCIA 250 mg POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION | ORENCIA 250 mg POLVO PARA CONCENTRADO PARA SOL. PARA PERFUSION, 1 vial | 250 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07389001/07389001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07389001/07389001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-06-15 | 1 | 1 | 1 | 2007-06-15 | 2007-06-15 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 693932 | 07389008 | ORENCIA 125 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | ORENCIA 125 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA , 4 jeringas precargadas de 1 ml | 125 mg | 33 | 4 | 61 | 4 jeringas precargadas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07389008/07389008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07389008/07389008_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2012-10-25 | 1 | 1 | 1 | 2012-10-25 | 2012-10-25 | 1 | 2013-09-02 | View Edit Delete | ||||||||||||
| 652611 | 07391001 | REVLIMID 5 MG CAPSULAS DURAS | REVLIMID 5 MG CAPSULAS DURAS, 21 cápsulas | 5 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391001/07391001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391001/07391001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663224 | View Edit Delete | |||||||||||
| 652629 | 07391002 | REVLIMID 10 MG CAPSULAS DURAS | REVLIMID 10 MG CAPSULAS DURAS, 21 cápsulas | 10 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391002/07391002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391002/07391002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663222 | View Edit Delete | |||||||||||
| 652645 | 07391003 | REVLIMID 15 MG CAPSULAS DURAS | REVLIMID 15 MG CAPSULAS DURAS, 21 cápsulas | 15 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391003/07391003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391003/07391003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663223 | View Edit Delete | |||||||||||
| 652652 | 07391004 | REVLIMID 25 MG CAPSULAS DURAS | REVLIMID 25 MG CAPSULAS DURAS, 21 cápsulas | 25 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/07391004/07391004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07391004/07391004_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | BRISTOL MYERS SQUIBB S.A. | 2007-07-02 | 1 | 1 | 1 | 2007-07-02 | 2011-10-05 | 1 | 2012-01-02 | 663225 | View Edit Delete | |||||||||||
| 683784 | 07392003 | CIRCADIN 2 mg COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS) | CIRCADIN 2 mg COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS), 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07392003/07392003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07392003/07392003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31764 | EXELTIS HEALTHCARE S.L. | 2011-09-12 | 1 | 1 | 1 | 2011-09-12 | 2011-09-12 | 1 | 2013-03-13 | View Edit Delete | ||||||||||||
| 770009 | 07392003IP | CIRCADIN 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS) | CIRCADIN 2 MG COMPRIMIDOS DE LIBERACION PROLONGADA (30 COMPRIMIDOS), 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07392003IP/07392003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07392003IP/07392003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31764 | MELYFARMA S.L. | 2026-02-27 | 1 | 1 | 1 | 2026-02-28 | 2026-02-27 | 1 | 2026-04-14 | View Edit Delete | ||||||||||||
| 659702 | 07393001 | SOLIRIS 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION | SOLIRIS 300 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 30 ml | 300 mg | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07393001/07393001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07393001/07393001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 31986 | ALEXION PHARMA SPAIN S.L.U. | 2007-08-07 | 1 | 1 | 1 | 2007-08-07 | 2007-08-07 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 659373 | 07396001 | PERGOVERIS 150 UI/75 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | PERGOVERIS 150 UI/75 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 vial de disolvente | 150 UI/75 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07396001/07396001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07396001/07396001_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29251 | MERCK S.L. | 2007-07-03 | 1 | 1 | 1 | 2007-07-03 | 2007-07-03 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 659374 | 07396003 | PERGOVERIS 150 UI/75 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | PERGOVERIS 150 UI/75 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 10 viales + 10 viales de disolvente | 150 UI/75 UI | 45 | 10 | 34 | 10 viales + 10 viales de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07396003/07396003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07396003/07396003_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29251 | MERCK S.L. | 2007-07-03 | 1 | 1 | 1 | 2007-07-03 | 2007-07-03 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 665781 | 07397001 | SIKLOS 1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SIKLOS 1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 1.000 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07397001/07397001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07397001/07397001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44000 | NORGINE DE ESPANA S.L.U. | 2010-06-25 | 1 | 1 | 1 | 2010-06-25 | 2010-06-25 | 1 | 2012-10-29 | View Edit Delete | ||||||||||||
| 687105 | 07397002 | SIKLOS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | SIKLOS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 100 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07397002/07397002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07397002/07397002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 44000 | NORGINE DE ESPANA S.L.U. | 2012-01-18 | 1 | 1 | 1 | 2012-01-18 | 2012-01-18 | 1 | 2013-04-01 | View Edit Delete | ||||||||||||
| 659519 | 07400008 | MIRCERA 50 microgramos/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | MIRCERA 50 microgramos/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada 0,3 ml | 50 microgramos | 33 | 1 | 61 | 1 jeringa precargada 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07400008/07400008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07400008/07400008_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2007-07-31 | 1 | 1 | 1 | 2007-07-31 | 2007-07-31 | 1 | 2012-01-09 | View Edit Delete |
Page 28 of 1036, showing 20 records out of 20715 total, starting on record 541, ending on 560